Japanese Device Makers Look To China For Increased Sales
This article was originally published in PharmAsia News
Japan’s makers of medical devices previously reliant on domestic sales are looking to China for growth, among them Sysmex, which expects to more than double its sales exports to China by the end of March.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.